A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events

2013 ◽  
Vol 82 (6) ◽  
pp. 968-975 ◽  
Author(s):  
Andrés M. Pineda ◽  
Francisco O. Nascimento ◽  
Solomon C. Yang ◽  
Ajay J. Kirtane ◽  
Robert J. Sommer ◽  
...  
Keyword(s):  
Medical Therapy ◽  
Patent Foramen Ovale ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Thromboembolic Events ◽  
Foramen Ovale ◽  
Cerebrovascular Events

scholarly journals Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism

2012 ◽  
Vol 5 (7) ◽  
pp. 777-789 ◽  
Author(s):  
Shikhar Agarwal ◽  
Navkaranbir Singh Bajaj ◽  
Dharam J. Kumbhani ◽  
E. Murat Tuzcu ◽  
Samir R. Kapadia
Keyword(s):  
Medical Therapy ◽  
Patent Foramen Ovale ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Paradoxical Embolism ◽  
Foramen Ovale

scholarly journals Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

2013 ◽  
Vol 34 (43) ◽  
pp. 3342-3352 ◽  
Author(s):  
Pablo Rengifo-Moreno ◽  
Igor F. Palacios ◽  
Parichart Junpaparp ◽  
Christian F. Witzke ◽  
D. Lynn Morris ◽  
...  
Keyword(s):  
Systematic Review ◽  
Randomized Controlled Trials ◽  
Medical Therapy ◽  
Patent Foramen Ovale ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Foramen Ovale ◽  
Vascular Events ◽  
Randomized Controlled

Is Transcatheter Closure Better than Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale? A Meta-analysis of Randomised Trials

2013 ◽  
Vol 22 (11) ◽  
pp. 903-909 ◽  
Author(s):  
Vinayak Nagaraja ◽  
Jwalant Raval ◽  
Guy D. Eslick ◽  
David Burgess ◽  
A. Robert Denniss
Keyword(s):  
Medical Therapy ◽  
Patent Foramen Ovale ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Cryptogenic Stroke ◽  
Foramen Ovale ◽  
Randomised Trials ◽  
Better Than

O113 Is Transcatheter Closure Better Than Medical Therapy For Cryptogenic Stroke With Patent Foramen Ovale? A Meta-Analysis Of Randomized Trials

Global Heart ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e30
Author(s):  
Vinayak Nagaraja ◽  
Jwalant Raval ◽  
Guy D. Eslick ◽  
David Burgess ◽  
A.Robert Denniss
Keyword(s):  
Medical Therapy ◽  
Patent Foramen Ovale ◽  
Randomized Trials ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Cryptogenic Stroke ◽  
Foramen Ovale ◽  
Better Than

scholarly journals COMPARISON OF DEVICES UTILIZED FOR TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE: A META ANALYSIS

2012 ◽  
Vol 59 (13) ◽  
pp. E238
Author(s):  
Shikhar Agarwal ◽  
Navkaranbir Bajaj ◽  
E. Murat Tuzcu ◽  
Samir Kapadia
Keyword(s):  
Patent Foramen Ovale ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Foramen Ovale

Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials

Angiology ◽  
2018 ◽  
Vol 70 (4) ◽  
pp. 325-331 ◽  
Author(s):  
Simone Vidale ◽  
Filippo Russo ◽  
Carlo Campana ◽  
Elio Agostoni
Keyword(s):  
Medical Treatment ◽  
Patent Foramen Ovale ◽  
Transcatheter Closure ◽  
Meta Analysis ◽  
Cochrane Library ◽  
Transient Ischemic Attacks ◽  
Foramen Ovale ◽  
End Points ◽  
Pfo Closure ◽  
New Onset

Cryptogenic strokes account for about 25% to 40% of total ischemic strokes, and 1 of the 3 of these have a patent foramen ovale (PFO). A meta-analysis concerning the effectiveness and safety of PFO closure in cryptogenic strokes or transient ischemic attacks (TIAs) was performed. We systematically searched Medline, Embase, and the Cochrane Library through April 2018. Eligible studies were randomized clinical trials. Primary and secondary end points were, respectively, stroke or TIA and stroke recurrences. We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for all end points using fixed- and random-effects meta-analyses. Data were included from 6 trials involving 3560 patients. In the pooled analysis, PFO closure was superior to medical treatment for both primary (RR: 0.39; 95% CI: 0.18-0.82; P < .02) and secondary end points (RR: 0.58; 95% CI: 0.44-0.76; P < .001). Transcatheter closure significantly increased the risk of new-onset atrial fibrillation (AF; RR: 5.74; P < .001). Percutaneous closure is superior to medical treatment in reducing stroke and TIA recurrence, even if with a significant risk increasing for new-onset AF. These findings suggest that transcatheter closure is indicated in patients with cryptogenic strokes and large PFO.

Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials

2018 ◽  
Vol 107 (9) ◽  
pp. 745-755 ◽  
Author(s):  
Volker Schulze ◽  
Yingfeng Lin ◽  
Athanasios Karathanos ◽  
Maximilian Brockmeyer ◽  
Tobias Zeus ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Randomized Controlled Trials ◽  
Medical Therapy ◽  
Patent Foramen Ovale ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Foramen Ovale ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document